Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Induced CD25 + CD127 dim Γδ Tregs in Acute Myeloid Leukemia Suppress the Activity of Normal Αβ T Cells

Shuang Liang, Jiangying Liu, Haitao Gao, Ruoyang Liu, Ning Wu, Tianhui Dong, Xiaojun Huang, MD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-136541

Published: 2020

Journal Articles

The Prognostic Significance of Wilms' Tumor Gene 1 in Adult AML with Different Risk Stratification Following Allo-HSCT

Ke Wang, Songhai Zhou, Yuqian Sun, MD, Chenhua Yan, Yu Wang, Xiaojun Huang, MD, Xiaosu Zhao, PhD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-139026

Published: 2020

Journal Articles

MEKK3 Regulates Angiogenesis through Smad Signaling

Rong Wei, Xiaojun Huang, MD, Bing Su

Blood (2020) 136 (Supplement 1): 7.

https://doi.org/10.1182/blood-2020-143395

Published: 2020

Journal Articles

Novel BCR-ABL1 Tyrosine Kinase Inhibitor (TKI) HQP1351 (Olverembatinib) Is Efficacious and Well Tolerated in Patients with T315I-Mutated Chronic Myeloid Leukemia (CML): Results of Pivotal (Phase II) Trials

Blood (2020) 136 (Supplement 1): 50–51.

https://doi.org/10.1182/blood-2020-142142

Published: 2020

Journal Articles

The Low Number of Mucosal-Associated Invariant T Cells in the Graft Was Associated with Occurrence of Gut Graft-Versus-Host Disease

Gao Mengge, Yan Hong, Yuqian Sun, MD, Jun Kong, MD, Chenhua Yan, PhD, Zhidong Wang, PhD, Yu Wang, Xiaojun Huang, MD, Xiaosu Zhao, PhD

Blood (2019) 134 (Supplement_1): 2001.

https://doi.org/10.1182/blood-2019-127722

Published: 2019

Journal Articles

Comparable Efficacy and Safety of Chinese Generic Imatinib and Branded Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Study

Xuelin Dou, Yazhen Qin, Yueyun Lai, Hongxia Shi, Xiaojun Huang, MD, Qian Jiang, MD

Blood (2019) 134 (Supplement_1): 2940.

https://doi.org/10.1182/blood-2019-130081

Published: 2019

Journal Articles

Donor and Host Coexpressing KIR Ligands Promote NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Xingxing Yu, Xiang-Yu Zhao, Zhengli Xu, Xunhong Cao, Mingrui Huo, Xiao-Su Zhao, Ying-Jun Chang, Yu Wang, Xiaohui Zhang, Lanping Xu, Kaiyan Liu, Xiaojun Huang, MD

Blood (2019) 134 (Supplement_1): 4519.

https://doi.org/10.1182/blood-2019-129609

Published: 2019

Journal Articles

Interferon-a-2b As a Maintenance Therapy Significantly Improves Disease-Free Survival in Patients with Low-Risk Acute Myeloid Leukemia

Xiaohong Liu, Wenbing Duan, Jing Wang, MD, Jinsong Jia, Lizhong Gong, Shen-ye Lu, MD, Xiaosu Zhao, PhD, Ying-Jun Chang, Yue-Yun Lai, Hongxia Shi, Yu Wang, Chenhua Yan, Xiaojun Huang, MD, Hao Jiang

Blood (2019) 134 (Supplement_1): 3823.

https://doi.org/10.1182/blood-2019-128505

Published: 2019

Journal Articles

An Updated Safety and Efficacy Results of Phase 1 Study of HQP1351, a Novel 3 rd Generation of BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI Resistant Chronic Myeloid Leukemia

Qian Jiang, MD, Xiaojun Huang, MD, Zi Chen, MD, Qian Niu, Lichuang Men, Hengbang Wang, PhD, Jiao JI, PhD MD, Bo Huang, Dayu Shi, Ting Zhao, Yue Hou, Dajun Yang, MD PhD, Yifan Zhai, MD PhD

Blood (2019) 134 (Supplement_1): 493.

https://doi.org/10.1182/blood-2019-124295

Published: 2019

Journal Articles

Dead/H-Box Helicase 11 ( DDX11 ) Mutations Correlate with Increased Relapse Risk in Persons with Acute Myeloid Leukaemia and Promote Proliferation and Survival of Human AML Cells in Vitro and in Immune Deficient Mice

Blood (2019) 134 (Supplement_1): 2732.

https://doi.org/10.1182/blood-2019-127831

Published: 2019

Journal Articles

The Lost or Absence of MRD<0.1% at Any Time after 2 Cycles of Consolidation Chemotherapy in CBFB-MYH11-Positive Acute Myeloid Leukemia Indicates Poor Prognosis

Wenbing Duan, Jinsong Jia, Jing Wang, MD, Xiaohong Liu, Lizhong Gong, Qian Jiang, MD, Ting Zhao, Yu Wang, Xiaohui Zhang, MD, Lanping Xu, Yanrong Liu, Yazhen Qin, Xiaojun Huang, MD, Hao Jiang

Blood (2019) 134 (Supplement_1): 2616.

https://doi.org/10.1182/blood-2019-126938

Published: 2019

Journal Articles

Pre-Emptive Tyrosine Kinase-Inhibitor Intervention Based on BCR/ABL1 Monitoring in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allo-HSCT: Two Independent Observational Cohort Study

Liu Hui, MD, Li Xuan, MD, Ren Lin, MD, Lan Deng, MD PhD, Fen Huang, MD, Zhiping Fan, MD, Danian Nie, MD, Xudong Li, Xinquan Liang, Dan Xu, Yu Zhang, Na Xu, MD, Jieyu Ye, MD PhD, Hua Jin, Dongjun Lin, MD, Liping MA, MD, Jing Sun, MD, Xiaojun Huang, MD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 3303.

https://doi.org/10.1182/blood-2019-126901

Published: 2019

Journal Articles

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

Can Liu, Ren Lin, Yu Wang, Fen Huang, MD, Zhiping Fan, MD, Shen Zhang, Yajing Xu, MD PhD, Ting Yang, Li Xuan, MD, Na Xu, Jieyu Ye, MD PhD, Jing Sun, Xiaojun Huang, MD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 5693.

https://doi.org/10.1182/blood-2019-132106

Published: 2019

Journal Articles

Detection of Measurable Residual Disease May Better Predict the Outcome Rather Than Mutations Based on Next-Generation Sequencing in Acute Myeloid Leukemia with Biallelic Mutations of CEBPA

Jing Wang, MD, Hao Jiang, Xiaojun Huang, MD, Guorui Ruan, Run-Qing Lu

Blood (2019) 134 (Supplement_1): 1449.

https://doi.org/10.1182/blood-2019-127696

Published: 2019

Journal Articles

Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3- itd Mutation

Blood (2019) 134 (Supplement_1): 1421.

https://doi.org/10.1182/blood-2019-127937

Published: 2019

Journal Articles

Costimulatory Molecule DNAM-1 Is Essential for Optimal NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Qiannan Shang, MBBS, Xingxing Yu, Xunhong Cao, Xuefei Liu, Zhengli Xu, Yingjun Chang, Xiaosu Zhao, PhD, Yu Wang, Xiaohui Zhang, MD, Lanping Xu, Xiaojun Huang, MD, Xiangyu Zhao

Blood (2019) 134 (Supplement_1): 3291.

https://doi.org/10.1182/blood-2019-130593

Published: 2019

Journal Articles

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Lijuan Hu, Qi Wang, PhD, Xiaohui Zhang, Lan-Ping Xu, MD, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Kaiyan Liu, MD PhD, Hui Wang, PhD, Xiaojun Huang, MD, Xiao-Dong Mo

Blood (2018) 132 (Supplement 1): 5757.

https://doi.org/10.1182/blood-2018-99-109858

Published: 2018

Journal Articles

Clinical Features and Early Effect in EVI1 Positive Acute Myeloid Lleukemia

Wenbing Duan, Lizhong Gong, Jinsong Jia, Honghu Zhu, MD, Xiaosu Zhao, Qian Jiang, PhD, Ting Zhao, Ya-Zhen Qin, Xiaojun Huang, MD, Hao Jiang, MD

Blood (2017) 130 (Supplement 1): 5026.

https://doi.org/10.1182/blood.V130.Suppl_1.5026.5026

Published: 2017

Journal Articles

Single Arm, Multi-Center, Phase II Study Of Clofarabine In Chinese Pediatric Patients With Refractory Or Relapsed Acute Lymphoblastic Leukemia

Leping Zhang, Xin Du, MD, Yan Li, MD, Zhen Cai, MD, PhD, Kang Yu, MD, Fenlai Tan, MD, PhD, Yi Fang, MD, Xiaojun Huang, MD, Jin Lu, MD

Blood (2013) 122 (21): 5016.

https://doi.org/10.1182/blood.V122.21.5016.5016

Published: 2013

Journal Articles

Non-Traditional CD4+ CD25–CD69+ Regulatory T Cells Is Correlated To Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Xiaosu Zhao, Xuhua Wang, Yingjun Chang, Xiangyu Zhao, Xiaohui Zhang, Daihong Liu, Lanping Xu, Kaiyan Liu, Xiaojun Huang, MD

Blood (2013) 122 (21): 3259.

https://doi.org/10.1182/blood.V122.21.3259.3259

Published: 2013

NARROW

Induced CD25 + CD127 dim Γδ Tregs in Acute Myeloid Leukemia Suppress the Activity of Normal Αβ T Cells

The Prognostic Significance of Wilms' Tumor Gene 1 in Adult AML with Different Risk Stratification Following Allo-HSCT

MEKK3 Regulates Angiogenesis through Smad Signaling

Novel BCR-ABL1 Tyrosine Kinase Inhibitor (TKI) HQP1351 (Olverembatinib) Is Efficacious and Well Tolerated in Patients with T315I-Mutated Chronic Myeloid Leukemia (CML): Results of Pivotal (Phase II) Trials

The Low Number of Mucosal-Associated Invariant T Cells in the Graft Was Associated with Occurrence of Gut Graft-Versus-Host Disease

Comparable Efficacy and Safety of Chinese Generic Imatinib and Branded Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Study

Donor and Host Coexpressing KIR Ligands Promote NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Interferon-a-2b As a Maintenance Therapy Significantly Improves Disease-Free Survival in Patients with Low-Risk Acute Myeloid Leukemia

An Updated Safety and Efficacy Results of Phase 1 Study of HQP1351, a Novel 3 rd Generation of BCR-ABL Tyrosine Kinase Inhibitor (TKI), in Patients with TKI Resistant Chronic Myeloid Leukemia

Dead/H-Box Helicase 11 ( DDX11 ) Mutations Correlate with Increased Relapse Risk in Persons with Acute Myeloid Leukaemia and Promote Proliferation and Survival of Human AML Cells in Vitro and in Immune Deficient Mice

The Lost or Absence of MRD<0.1% at Any Time after 2 Cycles of Consolidation Chemotherapy in CBFB-MYH11-Positive Acute Myeloid Leukemia Indicates Poor Prognosis

Pre-Emptive Tyrosine Kinase-Inhibitor Intervention Based on BCR/ABL1 Monitoring in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allo-HSCT: Two Independent Observational Cohort Study

Preemptive Therapy Based on the Load and Time of EBV-Emia for Preventing EBV Related PTLD after Haploidentical Hematopoietic Stem Cell Transplantation: A Prospective Multicenter Study

Detection of Measurable Residual Disease May Better Predict the Outcome Rather Than Mutations Based on Next-Generation Sequencing in Acute Myeloid Leukemia with Biallelic Mutations of CEBPA

Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3- itd Mutation

Costimulatory Molecule DNAM-1 Is Essential for Optimal NK Education Post Allogeneic Hematopoietic Stem Cell Transplantation

Positive Stool Cultures Could Predict the Clinical Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation

Clinical Features and Early Effect in EVI1 Positive Acute Myeloid Lleukemia

Single Arm, Multi-Center, Phase II Study Of Clofarabine In Chinese Pediatric Patients With Refractory Or Relapsed Acute Lymphoblastic Leukemia

Non-Traditional CD4+ CD25–CD69+ Regulatory T Cells Is Correlated To Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only